Donate

Prostate cancer kills 45 men
every hour.

“When my dad was diagnosed with prostate cancer I felt powerless.”
Read Andrew & Dave’s story
“I think everybody believes they’re going to live forever, even though they know they won’t. Nobody wants to be told, as I was last year, that they have five to seven years to live.”
Hear Jim’s story

Prostate cancer is the second most common cancer in men, and rates are on the rise. By 2030 there’ll be 1.7 million men living with prostate cancer. It’s already killing hundreds of thousands of men each year, and those who survive face serious side effects.

We can’t afford to let this continue.
So we’re taking action.

We’ve spent years learning how to tackle the toughest cancer challenges in innovative ways. Now it's time to draw a line in the sand.

 

By 2030 we’ll halve the number of men dying from prostate cancer.

We'll also halve the number of men facing serious ongoing side effects from prostate cancer treatment.

Help us get there.

Join up
Make a donation
 
 

“I'd like to imagine my son growing up in a world where prostate cancer can be cured. In a world where the way Dad freely talked about his health and his regular health checks isn’t unique, but the norm.”

Read Charlotte's story

This is how we’re going to win the fight.

Cancer research and care is full of difficult problems, but we’ve never been afraid of a challenge. We’ve spent years funding the most innovative and forward-thinking projects, getting the best researchers together to tackle the thorniest issues.
We’re focused on what works for men. From early detection through to diagnosis, treatment, and support: we’re not just looking for a cure. We’re looking for quality of life.

The plan of attack

1. Taking action early

Helping men know the signs, symptoms and risk factors for prostate cancer.

2. Bright minds brought together

We’re bringing the best minds from around the world together to collaborate.

3. Tackling biology

Increasing the knowledge of the most lethal prostate cancer tumours, and how to slow or stop its progression.

4. Reducing side effects

No matter where they are in the world, men and their families and carers must have access to services and support.

5. Affordable treatment

We’re influencing governments to provide affordable treatment and to get new treatments into practice faster.

6. Tailored treatments, precision care

Personalised treatment is the new frontier of cancer research. From distinguishing between harmless and lethal cancers, to taking into account genes, lifestyle and environment: it means a better outcome for men.

7. Helping men make tough choices

Men need the right info to understand their diagnosis and make an informed decision when it comes to treatment.

8. Raising the standard

We’re identifying excellence in prostate cancer treatment and care, to reduce the number of men who aren’t getting the best outcome possible.

9. Global initiatives

Our three largest investments in prostate cancer are global programs that will mean better outcomes for men everywhere.

Download our investment strategy

"The things I did once I was diagnosed, are really the things I should’ve been doing for years before I was diagnosed."
Watch Ron's story
“When you’re diagnosed with cancer you’re given a lot of information and treatment options and it can be really overwhelming.”
Hear Kirk's story

We’ve funded more than 1,200 men’s health projects, in Australia and around the world. Here’s a snapshot of our work in prostate cancer.

Projects that span the globe

We link up researchers around the world and get results faster by encouraging collaboration. We share our successes and our failures, so the scientific community doesn’t waste time on duplicate research.

Global Action Plan

Our Global Action Plan (GAP) is an international research initiative that brings researchers together to tackle the toughest challenges in prostate and testicular cancer. Since GAP launched in 2011, it has formed 7 large-scale global initiatives supporting 350 researchers from 90 institutions across 20 countries.
Read more
 
 

TrueNTH

TrueNTH is a revolutionary global care program that helps men living with prostate cancer to access care and support that improves quality of life before, during and after treatment. It focuses on empowering men to make informed decisions when it comes to treatment and side effects. TrueNTH operates across 6 countries with a team of more than 80 collaborators.
Read more
 
 

Prostate Cancer Outcomes Global Initiatives

Our Prostate Cancer Outcomes (PCO) initiatives are transforming prostate cancer healthcare globally by building a better understanding of men’s experiences. By compiling reports from both doctors and patients throughout treatment and comparing this across regions, we’re forming a new benchmark for prostate cancer care. This program is working in 7 countries, with 40 collaborators and researchers.

Prostate cancer research breakthrough

Movember Foundation funded research has discovered that men have a genetic “fingerprint” within their prostate cancer cells which will help build a more tailored treatment plan for men. This will help avoid overtreatment and side effects.
Watch the video

Local impact

In addition to large-scale efforts that span the globe, we’re also making strides for men in Australia, in partnership with the Prostate Cancer Foundation of Australia.

Prostate cancer specialist nurses service

The first of its kind in Australia, this program offers the thousands of men diagnosed with prostate cancer each year accessible specialist nursing care through the entire cycle of their treatment.
Read more

Movember Young Investigator in Action

7 year Mo Bro Jeff Holst is a Movember Young Investigator whose research funded by the Movember Foundation and Prostate Cancer Foundation of Australia (PCFA) has led to a recent breakthrough.
Read more

Impact of exercise on prostate cancer patients

Working directly with patients in a clinical trial, Professor Galvão and his team have linked the impact of muscle loss and the benefits of exercise for prostate cancer patients.
Watch the video

See all prostate cancer projects

We’re already seeing results, but there’s still work to be done.

We’ve pushed prostate cancer research forward 50 years, but there’s so much yet to be done. Men are still facing life or death questions, invasive treatments, and serious side effects. They’re dying too young.

To get to where we want to be by 2030,
we need your help.

Join up
Make a donation